Studies using AborLink are hosted in a secure infrastructure with redundant availability exceeding .9998. Major release upgrades each year are included, and focus on expanded functionality useful to typical protocols.  

Arbor Research provides the technical resources to customize Arborlink to the needs of each study using numerous configuration options. Configuration costs and additional service costs are not included in the fix costs model, and should be budgeted as time and materials costs.

ArborLink combines features offered by many clinical trials solutions – such as real-time data validation and study management tools – with features needed for international observational studies. ArborLink responds uniquely with configurable protocols adapted for each translated language and medical culture, and implementation of the complex study and sampling protocols, and management of biosample collection and processing. ArborLink has been used for over 20 research study protocols in over 20 countries, with each ArborLink implementation configured to meet the unique needs of the study.

ArborLink is a success not in spite of the fact that Arbor Research is not a software development shop, but because of it. Our multidisciplinary collaboration among users, clinicians, analysts, and study monitors provides invaluable context and insight for IT development staff in providing a product with real value-added to each study it supports.

• Dialysis Outcomes and Practice Patterns Study (DOPPS), collecting longitudinal data from dialysis facilities in more than twenty countries. Funded by a consortium of private sponsors.
• Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS), collecting longitudinal data from dialysis facilities in several countries. Funded by a consortium of private sponsors.

• Chronic Kidney Disease Dialysis Outcomes and Practice Patterns Study (CKDOPPS), collecting longitudinal data from dialysis facilities in several countries. Funded by a consortium of private sponsors.

• Childhood Liver Disease Research Network (ChiLDReN) study supports the discovery of new diagnostic and treatment options for children with liver disease and those who undergo liver transplantation. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

• Lower Urinary Tract Dysfunction Research Network (LURN) studies the symptoms of lower urinary tract dysfunction (LUTD). Funded by the NIDDK.

• Cure Glomerulonephropathy Network (CureGN) is a multicenter cohort study of glomerular disease patients. Funded by the NIDDK and the National Institutes of Health (NIH). Separate instances are included for ancillary studies on bone disease.

• The Nephrotic Syndrome Study Network (NEPTUNE) is an integrated group of academic medical centers, patient advocate organizations (NephCure Kidney International and the Halpin Foundation), and clinical research resources dedicated to advancing the understanding and treatment of Minimal Change Disease (MCD).

• The study of Lost Wages Reimbursement to Potential Kidney Donors On Living Donation Rates performed a “first-of-its-kind” pilot study of the reimbursement of lost wages for kidney donors.

• Renal and Lung Living Donors Evaluation Study (RELIVE) provides valuable information on the outcomes of living kidney donation and living lung donation.

• Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) is a network of nine leading liver transplantation centers in the United States and Canada.

• Michigan Emergency Department Improvement Collaborative (MEDIC) Study is an integrated adult and pediatric, emergency medicine-led Collaborative Quality Initiative (CQI).  Participating Emergency Departments contribute to clinical registry  to identify best practices and improve performance, and track performance in quality of care measures.

•  BoneGN is a multi-site prospective, longitudinal study to assess determinants of impaired bone quality and strength in glomerular disease.